Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

151,921-151,980 of 319,975

filter-aware
41
Slide highlights company accolades and product trial availability.Overstock | Results Presentation Deck | 45 slides · Overstock
Conference presentation Investor relations 1 hit
42
Overstock | Results Presentation Deck | 45 slidesOverstock | Results Presentation Deck | 45 slides · Overstock
Conference presentation Investor relations Beat · Action1 hit
43
The slide acts as a closing summary and Q&A prompt.Overstock | Results Presentation Deck | 45 slides · Overstock
Conference presentation Investor relations Beat · Action1 hit
44
Overstock | Results Presentation Deck | 45 slidesOverstock | Results Presentation Deck | 45 slides · Overstock
Conference presentation Investor relations 1 hit
45
Includes a footnote explaining special legal charges and a standard non-GAAP disclaimer.Overstock | Results Presentation Deck | 45 slides · Overstock
Conference presentation Investor relations 1 hit
01
Slide 1
Pathward Financial | Results Presentation Deck | 26 slidesPathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · Attention1 hit
02
Pathward Financial | Results Presentation Deck | 26 slidesPathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · Attention1 hit
03
Includes specific metrics on EIP card issuance and PPP loan funding.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · Attention1 hit
04
The slide presents a comparative financial performance overview for a bank or financial institution.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · InterestLoop · Golden Circle1 hit
05
The slide includes a detailed breakdown of asset classes and a visual representation of the asset mix with aspirational targets.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · InterestLoop · Golden Circle1 hit
06
Includes three combo charts (bar + line) and supporting bulleted text.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · InterestLoop · Golden Circle1 hit
07
The slide highlights the impact of COVID-19 on loan portfolios and the bank's response in terms of allowance building and underwriting.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · InterestLoop · Golden Circle1 hit
08
Pathward Financial | Results Presentation Deck | 26 slidesPathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · Desire1 hit
09
The table shows that total exposure to these high-impact industries is limited to 9.8% of the total portfolio.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
10
The slide uses a donut chart to show portfolio segments and a list for geographic concentration.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
11
The slide includes a footnote clarifying the methodology (NAICS codes, exclusions, and total principal amount).Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
12
The slide provides detailed sub-sector breakdowns for Manufacturing and a pie chart for Utilities concentration.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
13
Includes footnotes regarding total gross loans and subsector definitions.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
14
The slide provides a detailed breakdown of loan exposure, asset quality, and pandemic-related relief efforts.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
15
Pathward Financial | Results Presentation Deck | 26 slidesPathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations 1 hit
16
Includes data on EIP (Economic Impact Payment) card balances impacting 3Q20 deposits.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations 1 hit
17
Pathward Financial | Results Presentation Deck | 26 slidesPathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations 1 hit
18
Includes a bar chart for interest rate sensitivity, a pie chart for asset pricing, and a combination chart for asset/liability gap.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations 1 hit
19
Includes trend charts for Tier 1 Leverage and Total Capital Ratios compared to regulatory minimums.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations 1 hit
20
Pathward Financial | Results Presentation Deck | 26 slidesPathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations 1 hit
21
The slide uses a matrix structure to map three strategic pillars against four operational dimensions.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · Action1 hit
22
Includes a table of financial metrics and a pie chart showing net revenue contribution by segment.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · Action1 hit
23
The slide illustrates a 'first out' waterfall structure for asset-backed lines of credit.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · Action1 hit
24
The slide illustrates a financial waterfall structure for credit risk management.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · Action1 hit
25
Includes a footnote regarding the exclusion of tax services NCOs and average loans.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · Action1 hit
26
Includes specific adjustments for EIP Cards.Pathward Financial | Results Presentation Deck | 26 slides · Meta Financial Group
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
The word cloud contains key company themes like 'Early memory stem cell', 'CAR-T', 'Allogenic', 'Oncology', and 'Curative'.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank 1 hit
02
Poseida Therapeutics | IPO Presentation Deck | 34 slidesPoseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank 1 hit
03
This is a standard IPO/follow-on offering summary table.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank 1 hit
04
Slide 3 of a pitch deck.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Golden Circle1 hit
05
The slide acts as a high-level summary of the company's value proposition and asset structure.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Golden Circle1 hit
06
The slide uses a modular framework to categorize the company's technological stack.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
07
The diagram illustrates the 'cut and paste' mechanism of the transposon system.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
08
The slide uses a visual metaphor of combining two existing technologies to create a superior third one.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
09
The slide uses a spectrum-style diagram to categorize delivery methods.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
10
The slide uses a categorization framework to map competitors against specific therapeutic modalities (Cell Therapies, Gene Therapies, Other).Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Market Size1 hit
11
The slide uses a Gantt-style chart to represent clinical trial progress for various oncology and gene therapy candidates.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
12
Poseida Therapeutics | IPO Presentation Deck | 34 slidesPoseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
13
The slide uses a process diagram to show cell differentiation and a callout box to list clinical benefits.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · ProductLoop · Cost Of Inaction1 hit
14
Poseida Therapeutics | IPO Presentation Deck | 34 slidesPoseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · ProductLoop · Cost Of Inaction1 hit
15
The slide highlights clinical trial results for an autologous product as a stepping stone to allogeneic development.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
16
Uses patient success stories as clinical evidence of product efficacy.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
17
Includes a process flow diagram and a specific technical callout for Cas-CLOVER gene editing.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
18
The slide uses a biological diagram to explain the mechanism of T-cell activation and a line chart to show the performance improvement.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
19
The slide uses two distinct chart types (bar and dot plot) to highlight two key performance metrics of the technology.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
20
The slide compares autologous (101) vs allogeneic (ALLO1) CAR-T therapy efficacy in tumor reduction.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
21
Slide 20 of a pitch deck, showing longitudinal efficacy data.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
22
Uses a before-after framing to contrast standard multi-dose therapy with the company's single-dose, self-renewing approach.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
23
Data presented at SITC 2017. Includes both imaging and caliper measurement data.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
24
The slide uses a quadrant key to identify T-cell subsets (Teff, TSCM, Tem, Tcm) and highlights the persistence of TSCM cells post-tumor elimination.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
25
The slide uses a combination of a table for market potential, a biological diagram for mechanism, and bar charts for efficacy and safety.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
26
The slide uses two line charts to demonstrate efficacy across two different cancer models.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank 1 hit
27
The slide highlights the technical advantage of the piggyBac system in delivering multiple genes for multi-target CAR-T therapies.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank 1 hit
28
Poseida Therapeutics | IPO Presentation Deck | 34 slidesPoseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank 1 hit
29
The slide uses a two-column layout to contrast technical capability (PiggyBac) with market breadth (indications).Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank 1 hit